Neurokinin-1 antagonists: A step change in prevention of postoperative nausea and vomiting?

British Journal of Anaesthesia

Volumn 103, Issue 1, 2009, Pages 5-6

  Rowbotham, D J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; CYCLIZINE; DEXAMETHASONE; DOLASETRON MESILATE; DROPERIDOL; GRANISETRON; LORAZEPAM; METOCLOPRAMIDE; NEUROKININ 1 RECEPTOR ANTAGONIST; OPIATE; PERPHENAZINE; PROCHLORPERAZINE; SCOPOLAMINE; TROPISETRON; ANTIEMETIC AGENT; NEUROKININ 1 RECEPTOR;

CLINICAL FEATURE; DRUG EFFICACY; DRUG INDICATION; EDITORIAL; GENERAL ANESTHESIA; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INCIDENCE; MEDICAL RESEARCH; MONOTHERAPY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; DRUG ANTAGONISM; NOTE;

ANTIEMETICS; HUMANS; POSTOPERATIVE NAUSEA AND VOMITING; RECEPTORS, NEUROKININ-1; TREATMENT OUTCOME;

EID: 67650756566     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep126     Document Type: Editorial

References (12)

1. Macario A, Weinger M, Truong P, Lee M. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg 1999; 88: 1085-91
2. Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 1999; 89: 652-8
3. Gan T, Sloan F, Dear GdL, El-Moalem HE, Lubarsky DA. How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesth Analg 2001; 92: 393-400
4. Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg 2006; 102: 1884-98
5. Kranke P, Schuster F, Eberhart LH. Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting. Expert Opin Pharmacother 2007; 8: 3217-35
6. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700
7. Carlisle J, Stevenson CA. Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2006; 3: CD004125
8. Heffernan AM, Rowbotham DJ. Postoperative nausea and vomiting - time for balanced antiemesis? Br J Anaesth 2000; 85: 675-7
9. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62-71
10. Diemunsch P, Joshi GP, Brichant J-F. Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting. Br J Anaesth 2009; 103: 7-13
11. Andrews PL, Bhandari P. Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology 1993; 32: 799-806
12. Apfel CC, Malhotra A, Leslie JB. The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting. Curr Opin Anaesthesiol 2008; 21: 427-32